Association of Contract Research Organizations (ACRO India) elected D A Prasanna, Founder and Chairman of Ecron Acunova CRO, unanimously as the Chairman of the Association. He took over from Apurva Shah, Group Managing Director, Veeda Clinical Research. Prasanna also serves on biotechnology vision group of Karnataka government.
Speaking on the appointment, D A Prasanna said, clinical research in India has contributed to bringing vaccines, drugs, devices to needy patients at affordable prices. India has made a name in the world in lowering healthcare costs through generics and building a reputation in development of biotech drugs and medical devices. In the last few years, clinical research has come under criticism as being unsafe and severe regulation has been imposed.
ACRO India works for promoting safe conduct of clinical research without impeding the development of much needed drugs for Indian patients. ACRO India will promote global best practices to make Indian research data useful to market drugs developed in India, across the world.
Prasanna has built an Indian CRO with presence in 28 countries and helped to bring advanced cell therapy drugs to generic drugs to Indian and global patients. He has experience in leveraging Asian competitiveness building successful global business in medical technology for GE and software for Wipro. He has held global CEO positions in GE Healthcare and was Vice Chairman of Wipro.
ACRO India founded in 2005 under the aegis of Confederation of Indian Industry (CII) for bringing all CRO’s operating in India on one common platform. ACRO India promotes quality research, uphold ethics, best practices, synergies amongst members, to deliberate and act upon common concerns, especially with regard to Indian regulations and industry environment. ACRO India represents the interests of Indian CROs to regional, national and international authorities and organizations.